These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

224 related items for PubMed ID: 6378550

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cefaclor and cefatrizine, new investigational orally administered cephalosporins. In-vitro collaborative evaluation against clinical bacterial isolates and comparison with related antimicrobics.
    Jones RN, Fuchs PC, Thornsberry C, Barry AL, Gavan TL, Gerlach EH.
    Am J Clin Pathol; 1979 Oct; 72(4):578-85. PubMed ID: 495560
    [No Abstract] [Full Text] [Related]

  • 6. In vitro activity of cefadroxil, cephalexin, cefatrizine and cefpirome in presence of essential and trace elements.
    Sultana N, Arayne MS.
    Pak J Pharm Sci; 2007 Oct; 20(4):305-10. PubMed ID: 17604254
    [Abstract] [Full Text] [Related]

  • 7. Comparison of in vitro activity of cephalexin, cephradine, and cefaclor.
    Bill NJ, Washington JA.
    Antimicrob Agents Chemother; 1977 Mar; 11(3):470-4. PubMed ID: 301005
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Resistance of gram-negative bacteria against cefaclor and other antibiotics (author's transl)].
    Schassan HH.
    Infection; 1979 Mar; 7 Suppl 6():527-31. PubMed ID: 399243
    [Abstract] [Full Text] [Related]

  • 16. Susceptibility of clinical isolates of gram-positive and gram-negative organisms to cefatrizine.
    Carlone NA, Cuffini AM, Forno Pizzoglio M, Cavallo G.
    Drugs Exp Clin Res; 1985 Mar; 11(7):447-51. PubMed ID: 3836867
    [Abstract] [Full Text] [Related]

  • 17. Comparative in-vitro activity of a new oral carbacephem, LY163892.
    Howard AJ, Dunkin KT.
    J Antimicrob Chemother; 1988 Oct; 22(4):445-56. PubMed ID: 3060458
    [Abstract] [Full Text] [Related]

  • 18. In vitro and in vivo evaluations of BMY-28100, a new oral cephalosporin.
    Tomatsu K, Ando S, Masuyoshi S, Kondo S, Hirano M, Miyaki T, Kawaguchi H.
    J Antibiot (Tokyo); 1987 Aug; 40(8):1175-83. PubMed ID: 3500158
    [Abstract] [Full Text] [Related]

  • 19. In vitro activity of cefaclor, a new orally administered cephalosporin antibiotic.
    Santoro J, Levison ME.
    Antimicrob Agents Chemother; 1977 Sep; 12(3):442-3. PubMed ID: 907337
    [Abstract] [Full Text] [Related]

  • 20. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC, Ho SW.
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.